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Abstract: The antispasmodic effects of acqueous extracts (AE) and tinctures (T) of 
Aloysia polystachya (Griseb.) Moldenke and Aloysia gratissima (Gillies & Hook.) 
Tronc., Verbenaceae, were studied on rat isolated ileum and duodenum. These 
plants are used for gastrointestinal disorders and as eupeptic in South America. 
Both AE non-competitively inhibited the dose-response curves (DRC) of ACh 
and the DRC of Ca2+ in high-[K+]o, as well as the T. The T of A. polystachya and 
A. gratissima respectively inhibited the ACh-DRC at the IC50 of 3.15±0.57 and 
6.46±2.28 mg leaves/mL. The Ca2+-antagonist activity of both T occurred with 
IC50 respectively similar to those of the ACh-DRC, and was potentiated by the 
depolarization produced by 10 mM TEA, a blocker of K+-channels. The spasmolytic 
effect of T does not involve DA release and binding to D2, since it was not reduced 
by 10 µM metoclopramide. Also, T induced dose-dependent relaxation on the tonic 
contracture produced by high-[K+]o and ACh. By TLC there were detected in the 
leaves the presence of carvone, and flavonoids such as quercetin and hesperidin. 
By HPLC there were not found vitexin nor isovitexin, identified in A. citriodora. 
The monoterpene (-)-carvone non-competitively inhibited the ACh-DRC (pD´2 of 
4.0±0.1) and the DRC of Ca2+ (pD´2 of 3.86±0.19), suggesting that the Ca
2+-influx 
blockade is the mechanism of its antispasmodic effect. Results suggest that the 
antispasmodic effect of A. polystachya and A. gratissima are mostly explained by 
the non-competitive blockade of Ca+2 influx. It could be associated to the presence 
of flavonoids, and in the tinctures to some spasmolytic components of the essential 
oil such as carvone. 
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Introduction
 Many plants are used in folk medicine to treat 
gastrointestinal disorders, such as spasm or indigestion. 
Several plants of the genus Aloysia, Verbenaceae, are 
used as eupeptic in South America. In a previous work it 
was described for the first time the antispasmodic effect 
of Aloysia citriodora Ortega ex Pers., which is known 
as “cedrón” or “hierba luisa”. Its pharmacological 
mechanism of action was related to activation of the 
guanylil-cyclase and the potassium channels (Ragone 
et al., 2007). In this work, the antispasmodic properties 
of two other species of Aloysia were validated and 
the pharmacological basis of the popular use was 
evaluated, as well as the correlation with its chemical 
composition. These two species, Aloysia polystachya 
(Griseb.) Moldenke known as “burrito” or “té-burro” 
and Aloysia gratissima (Gillies & Hook.) Tronc. known 
as “palo amarillo”, are also used as eupeptic in South 
America. The leaves are prepared as an aromatic infusion 
commonly used as dietary supplement or eupeptic 
tea; and also as decoction or alcoholic tincture for 
abdominal pain or against nausea and dizziness (Soraru 
& Bandoni, 1978; Alonso & Desmarchelier, 2005). 
In spite of its wide use and the local experiences for 
cultivation (Burdyn et al., 2006) there were not studies 
about its gastrointestinal properties. Nevertheless, there 
were described anxiolytic and antidepressant effects 
of A. polystachya (Mora et al., 2005; Hellion-Ibarrola 
et al., 2008). Also, it has been described the presence 
of (-)-carvone in the essential oil of A. polystachya 
(Werdin-González et al., 2010), which was related to 
antispasmodic effect of Mentha genus (de Sousa et al., 
2008; Goncalves et al., 2008) as well as other terpenic 
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compounds. 
 At a taxonomic level the genus Aloysia is 
related to the genus Lippia (Pascual et al., 2001), which 
is widely used in the North hemisphere and exhibits 
an antispasmodic activity. In this way, in this work we 
studied whether the aqueous extract and tinctures of 
A. polystachya and A. gratissima are antispasmodic on 
acethylcholine-induced contractions on the isolated rat 
intestine, and which are the mechanisms and relation 
to composition. Isolated rat duodenum and ileum were 
a useful model to study the gastrointestinal effects of 
the extract and drugs. They have muscarinic receptors 
and let to study the antispasmodic effects over the 
smooth muscle contractured by depolarization or 
cholinergic stimulation (Karamenderes & Apaydin, 
2003; Emendorfer et al., 2005).
Materials and Methods
Plant material
 Aloysia polystachya (Griseb.) Moldenke 
and Aloysia gratissima (Gillies & Hook.) Tronc., 
Verbenaceae, were provided by a local herboristery, 
and the plants were authenticated by Prof. Dra. Etile 
Spegazzini with the voucher numbers 1153 (22-05-06) 
and 1155 (18-06-07) for A. polystachya and 1154 (23-
06-06) and 1156 (19-07-07) for A. gratissima (LPE). 
Their samples are kept in the Herbarium Museum 
of Botany and Pharmacognosy (LPE), Facultad de 
Ciencias Exactas, Universidad Nacional de La Plata, 
Argentina. 
Pharmacological studies
 Extracts preparation
 Aqueous extracts (AE) were prepared by 
boiling 20 g of dried leaves in 100 mL distilled water 
for 20 min, according to the ethomedicinal use. After 
filtration, the respective decoction was lyophilized, 
affording a 10% w/w yield. The lyophilized extract was 
diluted in distilled water and Tyrode solution for in vitro 
tests the day of each experiment. With this procedure, 
the essential oil is not included in the lyophilized 
sample. The ethanolic tinctures (T) were obtained by 
maceration during 8-10 h at 20% in ethanol 70º.
 Animals
 The research was conducted in accordance 
with the internationally accepted principles for the 
laboratory animal use and care as was established by 
US guidelines (NIH publication # 85-23 revised in 
1985).
 Biological preparation and contractile 
measurements
 Sprague-Dawley rats (200-250 g) were 
subjected to a 24 h fasting with free access to water 
before experimentation. The animals were anaesthetized 
by inhalation with diethyl ether and then quickly 
sacrificed by the opening of torax and abdomen, in 
order to avoid a relaxant effect of any other anaesthetic 
on the intestinal tissue.
 Duodenums and ileums (about 2 cm long) were 
prepared and mounted in organ baths of 20 mL containing 
Tyrode solution at 37 °C constantly oxygenated with air 
(pH 8.2) as in other works (Emendorfer et al., 2005). 
The preparations were equilibrated for at least 45 min 
at 1 g of pre-load. Tissues were connected to either, 
an isotonic force transducer Letica TRO 015 (PanLab, 
Spain) or an isometric one Power Lab MLT0201 
(Power Lab, AD Instruments). Both types of response 
were statistically compared in each protocol, without 
significant differences between results. Because of 
that, both types of data were mixed. The signals were 
acquired in a computer respectively by a National 
Instruments PC-516 NI-Daq SW with Virtual Bench 
logger and by Chart 4 of Power Lab program.
 Solutions and drugs
 The solutions used had the following 
composition: 
 Tyrode (Tyr): 150 mM NaCl, 2.7 mM KCl, 2 
mM MgCl2, 12 mM NaHCO3, 0.4 mM PO4H2Na, 1.8 
mM Ca Cl2 , bubbled with air (pH 8.2).
 Tyrode-0Ca: by eliminating Ca Cl2.
 Tyrode-0Ca-40 mM K+: by adding 0.6 ml KCl 
10% to 20 mL Tyrode 0Ca.
 The drugs employed in biological tests 
were: Acetylcholine bromide (ACh, Sigma, USA), 
tetraethylammonium chloride (TEA, Sigma, USA) 
and metoclopramide (Novartis) and the monoterpene 
(-)-carvone (Sigma, USA). For phytochemical assays 
there were used the flavonoids quercetin (Sigma, 
USA), vitexin (Extrasynthese, France), isovitexin 
(Extrasynthese, France) and hesperidin (Sigma, USA), 
and also (-)-carvone (Sigma, USA). The flavonoids 
were initially dissolved in dimethylsulphoxide (DMSO) 
as well as (-) carvone, and then diluted with water to 
obtain the lower concentrations. A DRC control was 
done with DMSO at 1% or Ethanol 1% in the Tyrode 
medium, which were respectively not different from 
the DRC without vehicle. 
Protocols
 Dose-response curves to acetylcholine
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 Dose-response curves (DRC) to acetylcholine 
(ACh) were done for the rats duodenums and ileums 
after a stabilization of 45 min. ACh concentrations 
were cumulatively added to the bath (to reach from 
0.01 to 10 μg/mL) in the absence and the presence of 
a unique concentration of either, the respective AE, the 
T, or a reference drug as it was shown in the respective 
figure. They were added 5 to 10 min before the DRC 
and remained during it in the bath, and control curves 
were done with the vehicle of the tinctures, ethanol 
of 70°. When several concentrations of AE or T were 
assed, a growing order of concentrations was used for 
making the DRC in each organ. 
 Dose-response curves to CaCl2
 After an stabilization during 45 min in Tyrode, 
the external Ca+2 was eliminated with Tyrode-0Ca 
and then, the muscle was depolarized with Tyrode-
0Ca-40 mM K+. The DRC of Ca2+ were obtained by 
cumulatively adding CaCl2 to reach concentrations from 
0.0195 to 17.5 mmol/L, in the absence and presence 
of growing concentrations of the respective AE or T. 
Each concentration of AE or T was added 5 min before 
the depolarization with high-K+ in Tyrode-0Ca and 
remained in the bath during it. 
 Dose relaxation curves of the extracts
 Tissues were contracted by depolarization 
with ClK 40 mM in the Tyrode until obtaining a tonic 
response. At this point, growing concentrations of AE 
(shown in the respective figure) were cumulatively 
added to construct a dose-relaxation curve. 
 In another group of muscles, the tonic 
contracture was obtained by adding 10 µg/mL 
acetylcholine (ACh). Then, the relaxation curves of AE 
or T were obtained in the absence and in the presence of 
40 mmol/L tetraethylammonium (TEA, a non-selective 
K+-channels blocker). 
Pharmacological and statistical analysis
 From the DRC there were calculated the pD2 
of the agonist (as -log EC50, in molar), and the affinity 
(pD’2) of the pure non-competitive antagonists as pD’2= 
-log [B’] + log [(EA-EAB’max)/(EA-EAB’)-1], where B’ is 
the concentration of the non-competitive antagonist, in 
molar, and EA, EAB’ and EAB’max are the maximal effects 
of the agonist respectively in the absence (A) and in the 
presence of either the used concentration of antagonist 
(B’) and the maximal concentration of it (B’max) 
(Van der Brink, 1977; Kenakin, 1984). In order to 
evaluate whether carvone act as competitive antagonist 
of ACh or Ca, the Schild method was applied for the 
50% effect of DRC and the linear correlation of log 
(concentrations ratio-1) vs. log[carvona] (in Molar) was 
statisticaly analyzed (Kenakin 1984; Wyllie & Chen, 
2007). For the extracts, the IC50 was calculated by 
extrapolation to 50% the individual relaxation curves 
obtained by plotting the maximal effect of the agonist 
from the respective DRC curves vs [extract] (expressed 
as mg lyophilized by mL). All results are expressed as 
media±ESM. Regression of DRC and statistics were 
done by using Graph Pad Prism 4.0 program, and by 
applying one-way ANOVA test for multiple comparisons 
followed by Tukey’s a posteriori tests. Paired t-test for 
comparison of paired results were also done. In all tests 
it was considered a significance of p<0.05.
Phytochemical studies
 HPLC analysis
 Since the presence of vitexin and isovitexin 
had been demonstrated in Aloysia citriodora leaves, it 
was evaluated whether these flavonoids were present 
in the AE of A. polystachya and A. gratissima. It was 
applied the previously developed method of high 
performance liquid chromatography (HPLC) contrasted 
with standards of both flavonoids (Ragone et al., 2007). 
It was used a 322-H2 series pump, a 155/156 UV/Vis 
detector and a work station equipped with the UniPoint 
LC, 3.3 version software (Gilson SAS, Villiers-Le-Bel, 
France). A Rheodyne 7125 manual sample injector 
(Rheodyne, CA, USA) with a fixed volume of 20 
µL was also used. Cromatographic conditions were: 
LiChrocart RP-18 (250 mm x 4 mm internal diameter, 
5 µm particle size) column (Merck, Darmstadt, 
Germany) as stationary phase under isocratic elution 
mode, at room temperature (25 °C). The mobile phase 
was composed by 2-propanol:tetrahydrofurane:water 
(5:15:85) at pH 4.33, flow rate was set at 1.0 mL/min 
and detected at 336 nm. The samples were prepared 
from the lyophilized AE of both plants, in the mobile 
phase at 700 µg/mL of concentration, which was filtered 
and injected by triplicate in the HPLC system. The 
following compounds were used as standard: vitexin 
and isovitexin. 
Total flavonoids content
 
 Total content of flavonoids was evaluated 
from the aerial parts of both, A. polystachya and A. 
gratissima, by adaptation of the Kostennikova method 
modified by Méndez (Gutiérrez-Gaitén et al., 2000). 
Briefly, 1 g of aerial parts were extracted at reflux 
during 2 h with 20 mL sol. 10% H2SO4 and 20 mL 
of ethanol 50°. After cooling, filtering, and washing 
with 30 mL ethanol 50°, it was evaporated on a water 
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boiling bath up to the half of volume, and cooling on 
an ice bath. The obtained precipitated was filtered and 
washing with cool water (10 °C, four times of 10 mL). 
Both, the precipitate and the remaining solid obtained 
during cooling, were dissolved again with ethanol 96° 
previously heated at 50 °C, transferred and completed 
volume to 100 mL with ethanol 96°. A volume of 5 mL 
of this solution was diluted to 100 mL (1:20) to read 
the absorbance at a wavelength of 285 nm (A285) on a 
Thermo spectrophotometer, Helios-beta model (Thermo 
Fisher Scientific, Waltham, MA, USA). As a standard 
it was used a 40 µg/mL solution of hesperidin (Sigma) 
in ethanol 50°, and this one was measured as a blank. 
Then, the standard and hydroalcoholic extractions of 
both species of Aloysia were submitted to the measure 
of an UV-spectra in the range of 200-400 nm in order to 
stablish the wavelength of maximum absorption. From 
those results, it was calculated the concentration of 
flavonoids in the sample expressed as µg/mL hesperidin 
(Cm) as Cm=Ch.Am/Ah, where Ch is the hesperidin 
concentration (in µg/mL), Am is the absorbance of 
the sample at 285 nm, and Ah is the absorbance of 
hesperidin at 285 nm. Then, it was calculated the % of 
total flavonoids expressed as hesperidin (g flavonoids 
by 100 g of aerial parts of the plant).
 TLC analysis
 The presence of the ketonic monoterpene 
(-)-carvone in both species of Aloysia was evaluated 
by thin-layer chromatography (TLC), on silica gel F 
254 Merck 0.25 mm and three systems of mobile phase: 
(a) toluene/ethylacetate (7:3), (b) toluene/ethylacetate 
(96:4), and (c) toluene/ethylacetate (9:1). The samples 
were 10% hexanic extractive solutions of the aerial parts 
of A. pachystachya and A. gratissima, and a standard of 
(-)-carvone (Sigma) at 1% in dichloromethane.
 The presence of flavonoids was evaluated 
by TLC on silica gel F254 Merck 0.25 mm and 
several mobile phases, as follows: (d) Cl2CH2/MeOH 
(95:5), (e) Cl2CH2/MeOH (99:1), (f) EtOAc/MeOH/
H2O (100:17:10), and (g) EtOAc/MetH/AcH/ H2O 
(100:11:11:26) (superior phase). As a standard it was 
used a 1% methanol solution of quercetin (Sigma). The 
detection of bands of flavonoids was performed under 
UV light (254 and 366 nm) with and without ammonia 
clouds, and with natural product spray (1% methanol 
solution of 2-amino ethyl-diphenil-boric acid) and it 
was observed under visible and UV light. The 10% 
methanol extractive solutions of aerial parts of both 
species of Aloysia and the lyophilized of 20% AE were 
run.
Results
Pharmacological studies
 The extract of both, Aloysia polystachya (AE-
A.p) and A. gratissima (AE-A.g) reduced the maximal 
effect of the DRC on a dose-dependent way (Figure 
1A), suggesting a non-competitive antagonism over the 
cholinergic contraction. The extrapolated IC50 of AE-
A.p was 1.8±0.27 mg lyophilized/mL, but for AE-A.g 
it was only possible to find an IC25 of 0.276±0.077 mg 
lyophilized/mL because it inhibited the DRC in a lower 
degree (Figure 1B). The tinctures of both plants also 
non-competitively inhibited the DRC of Ach in a higher 
degree than the AE (Figure 2), with IC50 of 3.15±0.57 
mg drug/mL for T-A.p and 6.46±2.28 mg drug/mL for 
T-A.g.
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Figure 1. Effects of Aloysia polystachya (a) and Aloysia 
gratissima (b) extracts on the dose-response curves of: 
acetylcholine (pD2: 5.77±0.13). Results as mean±SEM. 
Concentrations (mg lyophilized/mL) in labels. Two-way 
ANOVA by treatment: F=28.77, df 6, p<0.0001, by doses: F: 
161.3, p<0.0001, ,post-tests: *p<0.05 vs control.
a
b
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Figure 3. Relaxant effects on the tonic contractures of: (a) A. 
gratissima tincture on the high-K contracture vs. time; (b) A. 
polystachya AE and T on the ACh-contracture vs time, and 
(c) AE of both Aloysia spp on the ACh-contracture vs. extract 
concentrations. Results as mean±SEM. Concentrations (mg/mL) 
are shown in the figure with arrows.
 To assay whether the effects of both T on the DRC 
of ACh were associated to K+-channels activation, the 
DRC of ACh were done in the absence and the presence 
of 10 mM TEA. Figure 4 shows that TEA did not inhibited 
the non-competitive antagonism of T-A.p. and T-A.g. on 
DRC-ACh, but potentiated it. In order to evaluate whether 
that potentiation was due to the release of a relaxant 
neurotransmitter such as dopamine (DA) evoked by the 
depolarization due to TEA, the DRC of ACh was done 
in the presence of 10 mM TEA, 6 mg/mL T-A.p and 10 
mM metoclopramide to block the effect of dopamine in 
D2 receptors. The comparison of Figure 4A with Figure 
4C shows that this combined treatment did not reduce 
but increased the non-competitive blockade produced by 
T-A.p. and TEA.
 In order to elucidate whether the non-competitive 
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Figure 2. Effects of Aloysia polystachya (a) and Aloysia 
gratissima (b) tinctures on the dose-response curves of: 
acetylcholine. Results as mean±SEM. Concentrations (mg 
leaves/mL) in labels. Two-way ANOVA for (a): by treatment: 
F=173.9, df 3, p<0.0001, by doses: F: 137.6, df 8, p<0.0001; 
for (b): by treatment: F=61.32, df 4, p<0.0001, by doses: F: 
62.89, df 8, p<0.0001. Post-tests: *p<0.01 vs control.
 On the tonic contracture induced by Tyrode-K 
40 mM the EA-A.p did not produce relaxation, but EA-
A.g relaxed in a concentration-dependent way (Figure 
3A). A similar behavior of the EA was obtained when 
the tonic contracture was induced by ACh, in which 
only the EA-A.g relaxed in a concentration-dependent 
way and it was unaffected by the unspecific blocking 
of all types of K+-channels with 40 mM TEA (Figure 
3B). Nevertheless, both T-A.p. and T-A.g. relaxed in 
a concentration-dependent way the ACh-induced tonic 
contracture (Figure 3C). The effect of T-A.p. was not 
reduced but potentiated by the specific blocking of 
Ca2+-dependent K+-channels with 1 mM TEA.
a
b
a
b
c 
Antispasmodic effects of Aloysia polystachya and A. gratissima tinctures and 
extracts are due to non-competitive inhibition of intestinal contractility 
Alicia E. Consolini et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 21(5): Sep./Oct. 2011894
antagonism of both T on the ACh-DRC were associated 
to inhibition of Ca+2 influx to the smooth muscle, DRC 
of Ca+2 were done on high-K+-medium to activate the 
channels. Figure 5 shows that both, T-A.p and T-A.g 
produced a non-competitive inhibition of Ca+2 influx. The 
extrapolated IC50 were respectively 1.8±0.08 mg/mL for 
A. polystachya and 9.3±1.4 mg/mL for A. gratissima.
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Figure 4. Effects of Aloysia polystachya (a, c) and A. gratissima (b) 
tinctures on the dose-response curves of: acetylcholine in the absence 
(control) and the presence of 10 mM TEA and 10 µM metoclopramide. 
Results as mean ± SEM. Concentrations (mg leaves/mL) in labels. 
Two-way ANOVA for (a): by treatment: F=69.5, p<0.0001; for 
(b): by treatment: F=42.86, p<0.0001; for (c) by treatment: F: 368, 
p<0.0001. Post-tests: *p<0.05 vs the respective control.
 Effects of (-)carvone
 Since it was described the presence of (-)-carvone 
in the essential oil of A. polystachya (Werdin-González et 
al. 2010), it could contribute to the effects of tinctures. 
Since its mechanism has not been studied before, in this 
work we evaluated its effects on the DRC of ACh and 
Ca2+. Figure 6 shows that (-)-carvone developed a non-
competitive blockade of both DRC, since it decreased Emax. 
Also, the Schild method confirmed that (-)-carvone is not 
a competitive antagonist of ACh (slope different than 1) 
or Ca2+ (there is not significative linear correlation). From 
the DRC it was calculated the affinity of (-)-carvone on 
its own cellular site, which was estimated by the pD´2. It 
resulted 4.002±0.117 (n=20) from the DRC of ACh and 
3.86±0.19 (n=18) from the DRC of Ca2+.
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Figure 5. Effects of Aloysia polystachya (a) and A. gratissima 
(b) tinctures on the dose-response curves of calcium in the 
high-K Tyrode. Two-way ANOVA for (a): by treatment: 
F=258.9, df 3, p<0.0001, by doses: F: 577, df 5, p<0.0001; for 
(b): by treatment: F=449.3, df 2, p<0.0001, by doses: F: 175.4, 
df 5, p<0.0001 Post-tests: *p<0.05 vs control.
Phytochemical assays
 HPLC determinations
a
b
a
b
c
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 Contrarily to what was described for Aloysia 
citriodora (Ragone et al., 2007) the HPLC chromatograms 
showed no presence of vitexin or isovitexin in the AE of 
Aloysia polystachya and Aloysia gratissima (Figure 7). 
Retention times of the standard drugs were Rt 11.51 min for 
vitexin and 16.85 min for isovitexin, with a good separation 
profile comparable to that previously described.
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Figure 6. Effects of (-)-carvone on the dose-response curves of: 
(a) ACh (n=4, see pD’2 of carvone); and (b) Ca2+ (n=4, see pD´2 
of carvone). Two-way ANOVA for (a): by treatment: F: 43.23, 
df 5, p<0.0001, by doses: F: 52.58, df 7, p<0.0001; for (b): by 
treatment: F: 4.702, df 5, p=0.0006, by doses: F: 195.1, df 7, 
p<0.0001. Post-tests: *p<0.05 vs. control. In (c) are shown the 
Schild graphs obtained from the DRC of ACh (at left) and Ca2+ 
(at right) and the linear correlation results, which demonstrate the 
absence of competitive antagonism.
Total content of flavonoids
 Figure 8 shows that hesperidin exhibited a 
maximum absorption at 285 nm with a lower peak 
absorption at 230 nm. The extractives from A.polystachya 
and A.gratissima exhibited also two peaks at 285 nm and 
330 nm, by which it was chosen the wavelength of 285 nm 
for measuring. Table 1 shows the results of absorbance as 
well as the calculated % of flavonoids total content.
Table 1. Results of absorbance and total content of flavonoids 
expressed as hesperidin.
Hesperidin 
(40 µg/mL)
Extractive solutions 
A. polystachya A. gratissima
Absorbance at 285 nm 0.627 0.330 0.277
Concentration in the 
1:20 dilution (µg/mL) --- 21 17.67
% total flavonoids 
in the plant (g 
flavonoids/100 g 
aerial parts)
--- 4.2% 3.53%
Table 2. Chromatographic TLC results of the methanol extracts 
of Aloysia spp (EtOAc/MeOH/H2O 100:17:10). 
Aloysia pachystachya Aloysia gratissima Quercetin 
--- 0,40
Blue-clear fluorescence 
(UV 366)
0.50 
Yellow-orange
0.50 
Yellow-orange
0.60 
Brown
0.60 
Brown
0.64 
Brown
0.64 
Brown
0.68 
Brown
0.68 
Brown
0.71 
Brown
0.71 
Brown
0.78 
Brown
0.78 
Brown
0.80 
Yellow-orange
0.80 
Yellow-orange
0.85 
Yellow-orange
0.85 
Yellow-orange
0.90 
Yellow-orange
0.90 
Yellow-orange
0.90 
Yellow-orange
1.00 1.00
 TLC results
 Table 2 shows the results obtained with TLC 
for detecting the presence of flavonoids in the systems of 
higher resolution. The methanol extracts of both plants 
Results show Rf values, colour at visible with natural products reactive 
and/or fluorescent aspects at UV 366.
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Table 3. Chromatographic TLC results of the hexane extracts of Aloysia spp.
Toluene/EtOAc 96:4 Toluene/EtOAc 9:1
Aloysia pachystachya Aloysia gratissima Carvone Aloysia pachystachya Aloysia gratissima Carvone
0 
Violet-blue
0 
Violet-blue
0.00  
Violet-blue
0.00  
Violet-blue
0.13 
Violet-blue
0.13 
Violet-blue
0.17 
Violet-blue
0.17 
Violet-blue
0.17 
Violet-blue
0.17 
Violet-blue
0.25 
Violet-blue
0.25 
Violet-blue
0.25 
Blue-clear fluorescence  
(UV366)
0.25 
Blue-clear fluorescence 
(UV366)
0.30 
Blue-clear fluorescence 
(UV366) 
0.30 
Blue-clear fluorescence 
(UV366)
0.30 
Violet-blue
0.30 
Violet-blue
0.38 
Violet-blue
0.38 
Violet-blue
0.40 
Violet 
0.40 
Violet
0.40 
Violet
0.45 
Violet (very low)
0.45 
Violet (very low)
0.60 
Violet-blue
0.60 
Violet-blue
0.50 
Violet
0.50 
Violet
0.50 
Violet
1.00 
Violet-blue
1.00 
Violet-blue
0.58 
Violet-blue
0.58 
Violet-blue
1.00 
Violet-blue
1.00 
Violet-blue
Table shows Rf values, colour at visible in the presence of sulphuric anisaldehyde and/or fluorescence aspect at UV 366.
 Figure 7. HPLC traces of the standard solutions of vitexin (first peak) and isovitexin (second peak) (a) in comparison with the 
HPLC traces of the aqueous extract of Aloysia polystachya (b) A. gratissima (c) and A. citriodora (d). Retention time scale in 
minutes are detailed in the text. 
a b
c d
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glycosides, the stronger at Rf 0.50. The band at Rf 0.90 
is similar to that of the standard, the flavonol quercetin. 
On this system, the aglycons flavonoids run with the front 
of mobile phase (Rf 0.80 a 1.00) while the glycosides run 
in the middle. The AE of A. polystachya developed three 
bands of very low intensity (Rf 0.45; 0.60 and 0.80) which 
correspond with those of the methanolic extract. The AE of 
A. gratissima only showed two bands (Rf 0.45 and 0.80).
 Table 3 shows the results of TLC done with 
the hexane extractives of both Aloysia spp. The ketonic 
monoterpene (-)-carvone was used as a standard. The 
cromatographic profiles are very similar for both species. 
At 254nm there were found 6 bands with Rf between 0 and 
0.60. One of them (Rf 0.40) has the same Rf and aspect 
than that of the standard (-)-carvone. At 366 nm it appears 
a band with blue clear fluorescence (Rf 0.25), which does 
not react with sulphuric anisaldehyde. With this compound 
were seen the same seven bands, from which it is stronger 
the band of Rf 0.30 in violet. In system (c) there were 
found similar profile of bands for both Aloysia spp., except 
a low-intensity band at 0.45 in A.polystachya. In both, a 
band at Rf 0.30 with blue clear fluorescence appears at 
366, which does not react with sulphuric anisaldehyde. 
Also, there is a band at Rf 0.50 which became red violet 
after sulphuric anisaldehyde, with Rf and aspect similar to 
that of (-)-carvone. Then, TLC results suggest that both 
species of Aloysia have similar content in monoterpenic 
compounds, such as carvone.
Discussion
 This work gives support to the popular use of 
Aloysia polystachya (“burrito”) and A. gratissima (“palo 
amarillo”) as antispasmodic, since both directly relaxed the 
intestinal smooth muscle and non-competitively inhibited 
the DRC of ACh. There were assessed two phytotherapic 
preparations, the tinctures obtained by maceration (T) 
and the aqueous extract obtained by decoction (AE). The 
T induced a higher antispasmodic effect than the AE, as 
it was evidenced by the higher reduction in the effects of 
ACh (see the Emax of the DRC). These differences suggest 
either that the ethanolic maceration could extract more 
active principles or that these ones are thermo-sensitives. 
The non-competitive inhibition of the ACh effect suggests 
that one or more active principles would be interacting 
with a cellular site different from the muscarinic receptor, 
as it is classically interpreted from the DRC (Van der 
Brink, 1977; Kenakin, 1984). Several antispasmodic plants 
demonstrated to be non-competitive antagonists of ACh 
on duodenal or ileal smooth muscles (Sánchez de Rojas 
et al., 1995; Karamenderes & Apaydin, 2003; Camara et 
al., 2003; Emendorfer et al., 2005). This behaviour was 
also found in flavonoids, such as quercetin (Di Carlo 
et al., 1999). The presence of flavonoids as quercetin 
was evidenced in the AE by TLC, which could explain 
 
Figure 8. UV Spectrum of hesperidin standard (a), and the 
extractive solutions of A. polystachya or “burrito” (b) and A. 
gratíssima or “palo amarillo” (c).
yielded until 10 common bands with Rf between 0.50 and 
1.00. The extract of A. gratissima has another extra band 
at Rf 0.40 with strong blue clear fluorescence. According 
to Wagner & Bladt (1995) this is typical of extracts with 
flavonoids containing phenol-carboxylic acids, such as 
caffeic and chlorogenic acids. After boric acid, they appear 
until four bands yellow-orange (Rf 0.50; 0.80; 0.85 and 
0.90) characteristics of flavonols and flavones and their 
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part of the effects of both Aloysia spp. It was reported 
previously that quercetin relaxed the high-K+ contracture 
on rat intestine (Ragone et al., 2007) and guinea-pig 
ileum (Di Carlo et al., 1999). Also, the total content of 
flavonoids was estimated by a method which compares 
the UV-absorption spectrum of the extracts with that of 
hesperidin. This compound could be present among other 
flavonoids, according to the characterization done by 
TLC. The flavonoids total content of A. pachystachya was 
slightly higher than that of A. gratissima. This difference 
could be the origin of the pharmacological differences: A. 
pachystachya induced higher reduction of the ACh effect 
than A. gratissima in the extracts, and higher potency in 
the tinctures (IC50 of 3.14±0.57 vs 6.46±2.28 mg/mL, 
respectively). Nevertheless, the flavonoids vitexin and 
isovitexin were not found by HPLC in A. polystachya or 
A. gratissima. These flavonoids have been identified in 
the AE of Aloysia polystachya in which explain part of 
the antispasmodic effect (Ragone et al., 2007), and there 
were also described in other plants as the genus Passiflora 
(Muller et al., 2005). Then, the antispasmodic effects of 
the species of Aloysia could be related to several types of 
flavonoids which differ among them. 
 The first hypothesis underlying the non-
competitive inhibition of ACh contractions was that the 
plants could activate K+-channels, as Aloysia citriodora 
does. A K+-channel opener hyperpolarizes and relaxes the 
smooth muscles exposed to agonists but not those exposed 
to high-K+ depolarization, and this is used as a tool to 
evidence this mechanism (Karaki et al., 1997). Then, 
results of the AE and T on the tonic contractures induced 
by high [K+] and ACh suggested that A. polystachya could 
have that mechanism. Nevertheless, the relaxation was not 
inhibited by TEA at 10-40 mM (concentrations at which it 
non-selectively blocks all types of K+-channels), or TEA 
at 1 mM (which selectively block the Ca-dependent K+-
channels KCa without affecting the voltage-dependent 
ones, Kv) (Zhao et al., 2009). Contrarily, the non-
competitive inhibition of the T on the ACh dose-response 
curve was potentiated by TEA, suggesting that the 
depolarization induced by TEA could stimulate the release 
of a relaxant neurotransmitter such as dopamine (DA). 
Also, the depolarization could be contributing to activate 
and inactivate the Ca2+ channels and then, it could be the 
origin of the potentiated blockade of T on the smooth 
muscle. It would suggest that T may contain Ca-blockers 
among the active principles. The pre-treatment with the 
competitive antagonist of D2 receptor, metoclopramide, 
did not reduce the effect of T-A. polystachya. Then, 
the relaxant effect of T-A. polystachya with or without 
TEA was not due to release of dopamine acting on D2 
receptors. The potentiation of metoclopramide on the non-
competitive blockade of the T suggests also interaction 
with other constituents of the plant. 
 The following hypothesis was that the AE and 
especially the T have active principles which could 
act as antagonists of Ca+2 influx. This hypothesis was 
supported by the relaxation of the tonic contracture 
induced by high-K+ and ACh, and by the potentiation 
evoked by depolarization with TEA. The dose-response 
curves of CaCl2 were also non-competitively inhibited 
by the T of A. polystachya and A. gratissima. The IC50 
on the Ca2+-DRC were similar to (for A. gratissima) or 
lower than (for A. polystachya) the IC50 on the ACh-
DRC. These comparisons suggest that the blockade 
of Ca2+ influx would be responsible for the non-
competitive inhibition on the ACh-induced contractions. 
It is known that the interference with the Ca2+ channels 
may result competitive for drugs as dihydropiridines, 
but some other typical drugs as diltiazem or verapamil 
interfere in a non-competitive way with the internal 
sites of the channel (Karaki et al., 1997). Alternatively, 
other cellular sites could be affected by these plants, 
such as inhibition on calmoduline or sensitivity of 
actomyosin myofilaments (Karaki et al., 1997). The 
AE of A. citriodora also inhibited the DRC of Ca2+ in 
a non-competitive way, but the effect was associated 
to the activation of guanylil-ciclase and K+ channels 
(Ragone et al., 2007). The presence of flavonoids could 
also explain the Ca2+-blockade, since these compounds 
induce relaxation of smooth muscle and blockade 
of calcium influx (Gharzouli & Holzer, 2004). The 
taxonomically related genus Lippia also contains 
flavonoids (Skaltsa & Shammas, 1988) and exhibits 
antispasmodic properties. Nevertheless, the specific 
flavonoids seems to differ among the different species 
of Aloysia, especially A. citriodora.
 Furthermore, the presence of the ketonic 
monoterpene (-)-carvone was described in about an 85% 
in the essential oil of A. polystachya (Werdin-González 
et al., 2010). We found by TLC a similar band when 
there were assessed together the standard of this drug 
and the hexane extract of the aerial parts. The effect 
of (-)-carvone on smooth muscle was also assessed, 
finding that this compound non-competitively blocked 
the DRC of ACh and Ca2+, both with the same pD´2 
(about 4). This parameter estimates the affinity of a 
pure substance for its own receptor site, which differs 
from the agonist receptor. It is defined as the -log 
[antagonist] (in Molar) that reduces to the half the effect 
of the agonist (Kenakin et al., 1984). Also, the Schild 
analysis confirmed that (-)-carvone is not a competitive 
antagonist of ACh or Ca2+, since there was obtained 
either absence of correlation (for ACh) or a slope 
different than one (for Ca2+) according to Kenakin et al. 
(1984) and Wyllie & Chen (2007). Neither the pD´2 nor 
the Schild graphs could be calculated for the extracts or 
tinctures because they are not pure substances, but the 
DRC showed non-competitive antagonism because of 
the fall in Emax (Van der Brink, 1977). In spite of the 
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different parameters estimated (pD´2 vs IC50), either for 
the tinctures and for (-)-carvone assays, the parameters 
of inhibition on the DRC of ACh were similar to that 
of the DRC of Ca2+. It suggests that in tinctures as well 
as in (-)-carvone the Ca2+-influx blockade may be the 
origin of the interference with the ACh effect. Then, 
if considering that at least a fraction of the essential 
oil could be extracted in the tinctures, and that the 
pharmacological test is more sensitive than the TLC, 
it is possible to suggest that carvone could contribute 
to the effect of A. polystachya and A. gratissima 
tinctures. In summary, the results support the popular 
use of A. polystachya and A. gratissima as intestinal 
antispasmodics. Also, they are mostly explained by the 
non-competitive blockade of the Ca2+ influx. The effect 
was higher with the tinctures than with the acqueous 
extract, by which the maceration with ethanol of 70º 
must be extracting the active principles which cause 
the effect, such as some flavonoids and essential 
components as carvone. Since the flavonoids are 
known relaxants of the smooth muscle, their presence 
suggest that they would contribute to the antispasmodic 
effect of these plants. Here it is shown that also the 
monoterpene carvone could be in part responsible for 
the effect of the tinctures, since it non-competitively 
inhibits the effect of ACh and Ca2+ influx, at the same 
concentration range, as well as the tinctures.
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